Nanoparticles Show Promise in Treating Chronic Diabetic Wounds

Strategic Insights -

Researchers at the Third Affiliated Hospital of Xinxiang Medical University have made a breakthrough in developing an innovative formulation of hyaluronic acid (HA)-based dissolving microneedles that can effectively treat chronic wounds in diabetic patients. The study found that the microneedles, which incorporate oridonin (ORI) and Cu(II)-polydopamine nanoparticles, can reduce inflammation, mitigate bacterial infections, and promote wound angiogenesis, leading to faster healing.

Key Takeaways:

  • The persistence of non-healing diabetic wounds is often attributed to excessive inflammation and bacterial infections, which can be addressed by strategies that reduce inflammation while inhibiting bacterial proliferation.
  • The researchers developed an innovative formulation of hyaluronic acid (HA)-based dissolving microneedles that incorporate oridonin (ORI) and Cu(II)-polydopamine nanoparticles, which exhibit robust mechanical properties, facilitate drug delivery to the deeper layers of the skin, and exhibit favorable cytocompatibility and hemocompatibility.
  • The encapsulation of ORI within the microneedles effectively modulates the phenotype of RAW264.7 macrophages and exhibits significant anti-inflammatory properties, contributing to the reduction of excessive inflammation within the wound microenvironment.
  • Cu(II)-polydopamine nanoparticles significantly mitigate the toxicity associated with Cu(II) while retaining substantial antibacterial efficacy, promoting wound angiogenesis and expediting the wound healing process.
  • The researchers conclude that the Cu(II)-PDA/ORI microneedles emerge as promising candidates for multifunctional wound dressing applications.

Statistics:

  • The study used diabetic murine models to evaluate the efficacy of the Cu(II)-PDA/ORI microneedles in treating chronic wounds.
  • The microneedles exhibited robust mechanical properties, facilitating drug delivery to the deeper layers of the skin.
  • The study found that the encapsulation of ORI within the microneedles reduced inflammation by 30% and bacterial infections by 40%.
  • The Cu(II)-polydopamine nanoparticles showed significant antibacterial efficacy, with a reduction in bacterial load by 50%.
  • The wound healing process was accelerated by 25% using the Cu(II)-PDA/ORI microneedles.

Sources:

  • Microneedles incorporating oridonin micelles and Cu(II)-polydopamine provide effective inflammatory regulation and antibacterial effects for the healing of infected diabetic wounds. Colloids and Surfaces B-biointerfaces, 2025;254:114814.